TRIUS THERAPEUTICS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Trius Therapeutics, Inc. in Connection with Sale of Company to Cubist Pharmaceuticals, Inc.

NEW YORK--(BUSINESS WIRE)--

Levi & Korsinsky is investigating the Board of Directors of Trius Therapeutics, Inc. (“Trius” or the “Company”) TSRX for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Cubist Pharmaceuticals, Inc. CBST.

Click here to learn more about the investigation http://zlk.9nl.com/trius-therapeutics-tsrx/, or call: 877-363-5972. There is no cost or obligation to you.

Under the terms of the transaction, Trius shareholders will receive $13.50 in cash for each share of Trius stock they own. Trius shareholders will also be eligible to receive one Contingent Value Right of up to $2.00 per share should certain commercial milestones be met. The investigation concerns whether the Trius Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the transaction, and whether Cubist Pharmaceuticals, Inc. is underpaying for Trius, thus unlawfully harming Trius shareholders. In particular, at least one analyst set a price target for Trius stock at $20.00 per share.

If you own common stock in Trius and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/trius-therapeutics-tsrx/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.